Neurocrine Biosciences Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
145,739.00
193,809.00
379,191.00
307,350.00
515,929.00
650,913
Total Accounts Receivable
23.00
-
-
-
31,127.00
56,240
Other Current Assets
2,700.00
4,394.00
4,883.00
3,092.00
7,863.00
19,760
Total Current Assets
148,462.00
198,203.00
384,074.00
310,442.00
554,919.00
737,777
Net Property, Plant & Equipment
1,771.00
2,507.00
3,432.00
6,271.00
10,811.00
33,869
Total Investments and Advances
4,443.00
42,323.00
87,279.00
48,373.00
251,861.00
221,505
Total Assets
154,676.00
243,033.00
474,785.00
365,086.00
817,591.00
993,151
Accounts Payable
101.00
246.00
2,561.00
5,085.00
5,648.00
Other Current Liabilities
11,598.00
15,418.00
23,154.00
25,329.00
48,778.00
Total Current Liabilities
11,699.00
15,664.00
25,715.00
30,414.00
54,426.00
Long-Term Debt
-
-
-
-
369,618.00
Other Liabilities
22,567.00
18,670.00
24,616.00
19,795.00
21,409.00
Total Liabilities
34,266.00
34,334.00
50,331.00
50,209.00
445,453.00
Common Equity (Total)
120,410.00
208,699.00
424,454.00
314,877.00
372,138.00
Total Shareholders' Equity
120,410.00
208,699.00
424,454.00
314,877.00
372,138.00
Total Equity
120,410.00
208,699.00
424,454.00
314,877.00
372,138.00
Liabilities & Shareholders' Equity
154,676.00
243,033.00
474,785.00
365,086.00
817,591.00
About Neurocrine Biosciences
View Profile
